What's breaking now, across thousands of outlets.
Plus news about Frazier Life Sciences, BigHat Biosciences, Kasvu Therapeutics, Arcturus Therapeutics, Oruka Therapeutics and Viking Therapeutics. Sarepta Therapeutics settles gene therapy suit: Sarepta has agreed to pay Regenxbio $39 million to
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
While speaking with Norah O'Donnell on "Healthful, Dr. Jocelyn Wittstein called bone density loss a "silent disease" and said women should be getting Dual-Energy X-ray Absorptiometry, or DEXA, scans…
An Ontario Health Coalition report says operating rooms and diagnostic equipment are being underused in city hospitals like Ottawa.
One of the main reasons ovarian cancer is among the deadliest forms of cancer is timing: When doctors catch it early, the five-year survival rate can be more than 90%.
Identifying pancreatic cancer earlier in patients could give doctors more time to act before it becomes harder to treat.
I just delivered my baby and thought the hardest part was over. Instead, the postpartum period became the most life threatening.
